Stay updated on Tirzepatide in OSA: Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in OSA: Clinical Trial page.

Latest updates to the Tirzepatide in OSA: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRemoved the Obstructive Sleep Apnea topic from the page and deleted the related MedlinePlus Genetics topics link. This removes key context and labeling about the study's target condition.SummaryDifference0.1%

- Check24 days agoChange DetectedNew citation added: Malhotra et al. Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of SURMOUNT-OSA (Nat Med 2026). The previous online-ahead-of-print citation was removed; revision: v3.5.0.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded related topics: Obstructive Sleep Apnea and MedlinePlus Genetics as metadata; to avoid alerts for minor changes, set an alert condition.SummaryDifference0.1%

- Check60 days agoChange DetectedAdded a site revision label 'Revision: v3.4.2' and removed a government funding notice along with unrelated related-topic links (e.g., Obstructive Sleep Apnea, MedlinePlus Genetics) and a prior revision label; there are no changes to core study content, eligibility, outcomes, or participant information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check67 days agoChange DetectedAdded a site-wide notice about the lapse in government funding and NIH Clinical Center operating status, and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

Stay in the know with updates to Tirzepatide in OSA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in OSA: Clinical Trial page.